Navigation Links
DaVita Announces New Corporate Headquarters in Denver, Colorado
Date:5/27/2009

Central Operations of FORTUNE 500 Company to Be Located in Denver Metropolitan Area

DENVER, May 27 /PRNewswire-FirstCall/ -- DaVita Inc. (NYSE: DVA), a leading provider of kidney care services for those diagnosed with chronic kidney disease (CKD), today announced the home of its corporate headquarters will be located in Colorado. The announcement was made during a press conference on the Galleria of the Denver Performing Arts Complex by DaVita Chairman and Chief Executive Officer Kent Thiry, who was joined by Denver Mayor John Hickenlooper.

(Logo: http://www.newscom.com/cgi-bin/prnh/20020729/DAVITALOGO)

Thiry plans to move to the Denver area along with several other senior executives, but relocation efforts are not currently planned for teammates working in the current El Segundo, California headquarters or elsewhere around the company.

Since DaVita started in 1999, it has grown to become a FORTUNE 500(R) company with nearly $6 billion in annual revenues and clinical outcomes widely and consistently recognized as the best or among the best in the kidney care industry. The company operates more than 1,400 outpatient dialysis centers and acute units in more than 700 hospitals in 43 states and the District of Columbia. DaVita - which is Italian for "giving life" - currently has more than 32,000 teammates around the nation and serves more than 114,000 patients with life-saving kidney care treatment. In fact, nearly one-in-three dialysis patients in the United States is a DaVita patient.

"We're very pleased to announce our search is over and we've selected the Denver area to make our home," said Kent Thiry, Chairman and Chief Executive Officer of DaVita. "I want to thank Governor Ritter, Mayor Hickenlooper and their staffs for making such a tremendous effort in helping us choose Colorado."

The decision to select the Denver area for DaVita's corporate headquarters was based on four critical factors:

  1. The city's geographic location is ideal for a nationwide company with facilities and operations spread across nearly every state in the country;
  2. The relative costs in the area are less expensive for families and companies alike;
  3. Denver is widely considered to be a highly desirable place to live and work; and
  4. DaVita's significant existing presence in the region provides a solid foundation upon which the company can continue to grow.

The company expects to see millions of dollars in savings over time as a result of the change.

"DaVita's decision to move its headquarters is a great coup for metro Denver and the state of Colorado," said Denver Mayor John Hickenlooper. "DaVita is one of the biggest and the best in its industry. The company's decision reaffirms what we know is true about our community - that Denver is one of the best places in the nation to work and play. We are proud DaVita chose to call Colorado home."

"While Colorado families and businesses continue to struggle, we are clearly seeing encouraging signs of economic activity - and DaVita's decision to move its headquarters to Colorado tops the list," said Governor Bill Ritter. "Colorado's business-friendly climate and my administration's strategy to create new jobs, help businesses survive the downturn, and develop a highly skilled 21st century labor pool are positioning Colorado for a strong and sustainable recovery. On behalf of people throughout the state, we heartily welcome DaVita's Colorado expansion and we congratulate Mayor Hickenlooper and all those who helped make these new jobs a reality."

As part of DaVita's extensive network of outpatient facilities and acute units, DaVita has nearly 30 outpatient facilities statewide and a total of nearly 800 employees serving approximately 2,000 kidney care patients around the state.

DaVita(R) is a registered trademark of DaVita Inc. All trademarks are the property of their respective owners.

About DaVita Inc.

DaVita Inc., a FORTUNE 500(R) company, is a leading provider of kidney care in the United States, providing dialysis services and education for patients with chronic kidney failure and end stage renal disease. Recognized as the only FORTUNE 500 company on WorldBlu's annual list of "Most Democratic Work Places," DaVita manages more than 1,400 outpatient facilities and acute units in more than 700 hospitals located in 43 states and the District of Columbia, serving approximately 114,000 patients - nearly one-in-three of all dialysis patients in the United States. As part of DaVita's commitment to building a healthy, caring community, DaVita develops, participates in and donates to numerous programs dedicated to transforming communities and creating positive, sustainable change for children, families and our environment. For more information about DaVita, its kidney education materials and its community programs, please visit www.davita.com.


'/>"/>
SOURCE DaVita Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. DaVita Wins Eight Hermes Creative Awards Recognizing Excellence in Communications and Marketing
2. DaVita Becomes the First FORTUNE 500 Healthcare Services Company to Join the EPA Green Power Partnership
3. DaVita Announces Completion of Government Investigation
4. DaVita Donates More Than $1 Million in Scholarship Funds for Teammates Families
5. DaVita 1st Quarter 2009 Results
6. DaVita Wins Silver in Web Health Awards
7. DaVita Honored as First and Only FORTUNE 500 Company to Make List of Democratic Workplaces Since Its Inception in 1999
8. DaVita Dietitian Receives 2009 National Kidney Foundation Award for Outstanding Contributions to Renal Health
9. DaVita Wins Recruiting Department of the Year Award
10. Natalie Cole Lauds DaVita and CEO Kent Thiry on Larry King Live
11. DaVitas Customized Lifestyle Management Programs Assist Employees to Meet Their Lifestyle Goals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2016)... ... 27, 2016 , ... More than a third of American adults are considered ... surgery has received increased attention in recent years, as an article published ... weight loss, most people are familiar with the basic requirements of maintaining a healthy ...
(Date:5/27/2016)... ... ... With over 60 percent of acute stroke survivors being left unable to ... in the rehabilitation process has steadily increased. Ekso Bionics had been working to help ... stroke. , Ekso Bionics has now received clearance from the U.S. Food and Drug ...
(Date:5/27/2016)... ... May 27, 2016 , ... Aimed ... by inspiring human interest stories, courtesy of leaders in the nursing and health ... the industry, from leading advocates and associations—namely Jones & Bartlett Learning. , Jones ...
(Date:5/26/2016)... ... ... There are many ways to cook a hot dog, but new research commissioned ... dogs straight off the grill. Of the 90 percent of Americans who say they ... hot dog, far outpacing other cooking methods such as steaming (12 percent), microwaving (9 ...
(Date:5/26/2016)... , ... May 26, 2016 , ... Connor Sports, ... basketball as a partner for the Tamika Catchings Legacy Tour that will ... industry leader in hardwood basketball surfaces in all forms and levels of the game, ...
Breaking Medicine News(10 mins):
(Date:5/25/2016)... MedDay, a biotechnology company focused on the treatment ... "High doses of biotin in progressive multiple sclerosis: extension phase ... Ayman Tourbah , Principal Investigator of the Phase 3 ... Neurology (EAN) in Copenhagen, Denmark . The ... on Sunday, 29 May 2016 from 14:45 to 16:15 CEST ...
(Date:5/24/2016)... --   , ... Endpunkte und demonstriert Ebenbürtigkeit bei der Gesamtreinigung des ... guter , Reinigung des ... (Logo: http://photos.prnewswire.com/prnh/20130829/633895-a ) , ... der MORA-Studie der Phase III für NER1006 (1 ...
(Date:5/24/2016)... Celsion Corporation (NASDAQ: CLSN ... an update on its ongoing OVATION study, a ... the Company,s DNA-based immunotherapy, with the standard of ... advanced ovarian cancer who will undergo neoadjuvant chemotherapy ... IL-12 DNA plasmid vector formulated as a nanoparticle ...
Breaking Medicine Technology: